glp 1 drug liraglutide may protect against dementia Frontiers Promising New Data Support GLP-1s

They're not the same medication

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Within professional research environments, Tirzepatide is a primary compound of interest for investigating

Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors

There is no argument that the drugs are much more potent and faster acting than your bodies natural GLP-1 hormones

This comprehensive GLP-1 probiotic supplement combines ingredients traditionally associated with prebiotics, probiotics, and postbiotics in one supplement